Literature DB >> 20553754

CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells.

Maria-Elena Márquez1, Carmen Millet, Hilda Stekman, Angela Conesa, Pierre-Antoine Deglesne, Felix Toro, Juan De Sanctis, Isaac Blanca.   

Abstract

Human NK cells are classified into two populations according to the intensity of CD56 surface expression, as well as possession of CD16, FcRIII. CD56(dim)CD16(bright) make up 90% circulating NK cells, whereas CD56(bright)CD16(-/dim) comprises the remaining 10%. Here we report that peripheral NK cells upon CD16 cross-linking up-regulates the expression of activating markers and receptors such as CD25, CD69, NKp44, NKp30, CD40L and the intensity of CD56 expression. Additionally, co-culturing immature DCs with CD16 activated NK cells was found to significantly increase the expression of maturation markers on DCs. These results suggest that CD16 cross-linking on resting peripheral blood NK cells triggers the activation of these cells and induces the appearance of CD56(bright) NK cells. The latter were found capable of producing pro-inflammatory cytokines, IFN-gamma and TNF-alpha and notably IL-12. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553754     DOI: 10.1016/j.cellimm.2010.05.002

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  12 in total

Review 1.  Combination strategies to enhance antitumor ADCC.

Authors:  Holbrook E Kohrt; Roch Houot; Aurélien Marabelle; Hearn Jay Cho; Keren Osman; Matthew Goldstein; Ronald Levy; Joshua Brody
Journal:  Immunotherapy       Date:  2012-05       Impact factor: 4.196

2.  Co-stimulation of the fc receptor and interleukin-12 receptor on human natural killer cells leads to increased expression of cd25.

Authors:  Megan C Duggan; Amanda R Campbell; Elizabeth L McMichael; Kallan S Opheim; Kala M Levine; Neela Bhave; Michelle C Culbertson; Tiffany Noel; Lianbo Yu; W E Carson
Journal:  Oncoimmunology       Date:  2017-10-16       Impact factor: 8.110

Review 3.  Natural killer (NK) cells in antibacterial innate immunity: angels or devils?

Authors:  Fernando Souza-Fonseca-Guimaraes; Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

Review 4.  Natural killer (NK): dendritic cell (DC) cross talk induced by therapeutic monoclonal antibody triggers tumor antigen-specific T cell immunity.

Authors:  Steve C Lee; Raghvendra M Srivastava; Andrés López-Albaitero; Soldano Ferrone; Robert L Ferris
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 5.  The biology of natural killer cells during sepsis.

Authors:  Yin Guo; Naeem K Patil; Liming Luan; Julia K Bohannon; Edward R Sherwood
Journal:  Immunology       Date:  2017-11-16       Impact factor: 7.397

6.  The quantitative and functional changes of NK cells in mice infected with Angiostrongylus cantonensis.

Authors:  Ai-ling Chen; Xiao-yan Qiu; Wei Wang; Chun-lei Zhou; Xin Zeng; Xin-jian Liu; Jing-fan Qiu; Yong Wang
Journal:  Parasitol Res       Date:  2014-03-26       Impact factor: 2.289

7.  β-Adrenergic receptor mediated increases in activation and function of natural killer cells following repeated social disruption.

Authors:  Andrew J Tarr; Nicole D Powell; Brenda F Reader; Neela S Bhave; Amanda L Roloson; William E Carson; John F Sheridan
Journal:  Brain Behav Immun       Date:  2012-07-14       Impact factor: 7.217

8.  Patient-based transcriptome-wide analysis identify interferon and ubiquination pathways as potential predictors of influenza A disease severity.

Authors:  Long Truong Hoang; Thomas Tolfvenstam; Eng Eong Ooi; Chiea Chuen Khor; Ahmand Nazri Mohamed Naim; Eliza Xin Pei Ho; Swee Hoe Ong; Heiman F Wertheim; Annette Fox; Chau Van Vinh Nguyen; Ngoc My Nghiem; Tuan Manh Ha; Anh Thi Ngoc Tran; Paul Tambayah; Raymond Lin; Chariya Sangsajja; Weerawat Manosuthi; Chareon Chuchottaworn; Piamlarp Sansayunh; Tawee Chotpitayasunondh; Piyarat Suntarattiwong; Kulkanya Chokephaibulkit; Pilaipan Puthavathana; Menno D de Jong; Jeremy Farrar; H Rogier van Doorn; Martin Lloyd Hibberd
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 9.  Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy.

Authors:  Cariad Chester; Katherine Fritsch; Holbrook E Kohrt
Journal:  Front Immunol       Date:  2015-12-02       Impact factor: 7.561

10.  Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).

Authors:  Jia Wang; Richard A Urbanowicz; Patrick J Tighe; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.